Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials
Titel:
Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials
Auteur:
Leonardi, Craig Reich, Kristian Foley, Peter Torii, Hideshi Gerdes, Sascha Guenther, Lyn Gooderham, Melinda Ferris, Laura K. Griffiths, Christopher E. M. ElMaraghy, Hany Crane, Heidi Patel, Himanshu Burge, Russel Gallo, Gaia Shrom, David Leung, Ann Lin, Chen-Yen Papp, Kim